Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gabarre

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 TrialP Solal-Céligny, E Lepage, N Brousse, et al.
Haematologica|May 9, 2000
Phase II study of 3-hour infusion of high dose paclitaxel in refractory and relapsed aggressive non-Hodgkin's lymphomas. Groupe d'Etude des Lymphomes de l'AdulteR O Casasnovas, C Haioun, C Dumontet, et al.
The American Journal of Medicine|December 19, 2001
Human immunodeficiency virus-related lymphoma: relation between clinical features and histologic subtypesJ Gabarre, M Raphael, E Lepage, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Tumor necrosis factor alpha release is a major biological event associated with rituximab treatmentJ Bienvenu, R Chvetzoff, G Salles, et al.
Leukemia|February 1, 1997
Human herpes virus 8 (Kaposi's sarcoma herpes virus) and malignant lymphoproliferations in France: a molecular study of 250 cases including two AIDS-associated body cavity based lymphomasA Gessain, J Brière, C Angelin-Duclos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2015
Non-AIDS-related malignancies: expert consensus review and practical applications from the multidisciplinary CANCERVIH Working GroupJ-P Spano, I Poizot-Martin, D Costagliola, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2014
ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥ 4 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trialN Mounier, P Brice, S Bologna, et al.
Blood|October 6, 2001
Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapyC Besson, A Goubar, J Gabarre, et al.
Blood|July 14, 2017
FDG-PET-driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 studyR-O Casasnovas, L Ysebaert, C Thieblemont, et al.
Human Reproduction (Oxford, England)|May 23, 2019
Impact of cancer chemotherapy before ovarian cortex cryopreservation on ovarian tissue transplantationC Poirot, A Fortin, J M Lacorte, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 TrialP Solal-Céligny, E Lepage, N Brousse, et al.
Haematologica|May 9, 2000
Phase II study of 3-hour infusion of high dose paclitaxel in refractory and relapsed aggressive non-Hodgkin's lymphomas. Groupe d'Etude des Lymphomes de l'AdulteR O Casasnovas, C Haioun, C Dumontet, et al.
The American Journal of Medicine|December 19, 2001
Human immunodeficiency virus-related lymphoma: relation between clinical features and histologic subtypesJ Gabarre, M Raphael, E Lepage, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Tumor necrosis factor alpha release is a major biological event associated with rituximab treatmentJ Bienvenu, R Chvetzoff, G Salles, et al.
Leukemia|February 1, 1997
Human herpes virus 8 (Kaposi's sarcoma herpes virus) and malignant lymphoproliferations in France: a molecular study of 250 cases including two AIDS-associated body cavity based lymphomasA Gessain, J Brière, C Angelin-Duclos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2015
Non-AIDS-related malignancies: expert consensus review and practical applications from the multidisciplinary CANCERVIH Working GroupJ-P Spano, I Poizot-Martin, D Costagliola, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2014
ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥ 4 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trialN Mounier, P Brice, S Bologna, et al.
Blood|October 6, 2001
Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapyC Besson, A Goubar, J Gabarre, et al.
Blood|July 14, 2017
FDG-PET-driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 studyR-O Casasnovas, L Ysebaert, C Thieblemont, et al.
Human Reproduction (Oxford, England)|May 23, 2019
Impact of cancer chemotherapy before ovarian cortex cryopreservation on ovarian tissue transplantationC Poirot, A Fortin, J M Lacorte, et al.
Pageof 5